Inventor · disambiguated record
Hayley Reece
Also filed as: REECE HAYLEY · REECE HAYLEY A · Reece Hayley Ann
16 granted patents·11 pending applications·56 citations·filing 2012–2025
91Inventor score
Top patents by PatentIndex Score
27 records- 0194US8349891B2Crystalline solids of a MetAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2012·Granted Jan 8, 2013·28 cites·21 claims
- 0292US11020374B2Sulcardine saltsHUYA BIOSCIENCE INT LLC·Filed 2020·Granted Jun 1, 2021·4 cites·19 claims
- 0389US8735447B2Crystalline solids of a MetAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2012·Granted May 27, 2014·5 cites·17 claims
- 0487US12043612B2Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the sameARVINAS OPERATIONS INC·Filed 2021·Granted Jul 23, 2024·3 cites·12 claims
- 0587US11673918B2Method of manufacturing a pharmaceutical compositionFERRING BV·Filed 2021·Granted Jun 13, 2023·2 cites·13 claims
- 0683US10981955B2Method of manufacturing a pharmaceutical compositionFERRING BV·Filed 2018·Granted Apr 20, 2021·3 cites·25 claims
- 0782US11214536B2Polymorphs and uses thereofINSPIRNA INC·Filed 2018·Granted Jan 4, 2022·2 cites·9 claims
- 0881US12239631B2Polymorphs of phenyl pyrrole aminoguandium saltsSYNACT PHARMA APS·Filed 2024·Granted Mar 4, 2025·1 cites·27 claims
- 0978US9371312B2Crystalline solids of a MetAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2014·Granted Jun 21, 2016·1 cites·9 claims
- 1076US9827221B2Crystalline solids of a metAP-2 inhibitor and methods of making and using sameZAFGEN INC·Filed 2016·Granted Nov 28, 2017·1 cites·7 claims
- 1174US12139558B2Method of manufacturing a pharmaceutical compositionFERRING BV·Filed 2023·Granted Nov 12, 2024·0 cites·12 claims
- 1273US10385085B2Crystal forms of sialic acid or salt or solvate thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2016·Granted Aug 20, 2019·3 cites·16 claims
- 1372US9725454B2Crystalline forms of ponatinib hydrochlorideSANDOZ AG·Filed 2014·Granted Aug 8, 2017·3 cites·13 claims
- 1470US2025144072A9Sulcardine saltsHUYABIO INT LLC·Filed 2022·Application pending·0 cites
- 1565US11426382B2Sulcardine saltsHUYABIO INT LLC·Filed 2020·Granted Aug 30, 2022·0 cites·3 claims
- 1665US2025059168A1Crystalline and amorphous forms of a compound for the targeted degradation of estrogen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1763US2024409529A1Methods of Manufacturing a Bifunctional Compound, Ultrapure Forms of the Bifunctional Compound, and Dosage Forms Comprising the SameARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1861US2023271922A9Polymorphs of phenyl pyrrole aminoguandium saltsSYNACT PHARMA APS·Filed 2022·Application pending·0 cites
- 1960US12162859B2Crystalline and amorphous forms of a compound for the targeted degradation of estrogen receptorARVINAS OPERATIONS INC·Filed 2021·Granted Dec 10, 2024·0 cites·6 claims
- 2060US2025326785A1Sodium salt and ethanolamine salt of 23-hydroxytormentic acidHUYABIO INT LLC·Filed 2025·Application pending·0 cites
- 2158US2024327415A1Multicomponent Complexes, Including Salts, Crystalline Forms, and Hydrates and Solvates of ENT1 InhibitorsiTeos Belgium SA·Filed 2024·Application pending·0 cites
- 2249US2023339880A1Compositions of ajulemic acid and uses thereofCORBUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2348US10800801B2Crystalline platinum-based compoundsAKAMARA THERAPEUTICS INC·Filed 2017·Granted Oct 13, 2020·0 cites·23 claims
- 2447US2023391749A1Crystalline and amorphous forms of a delta-opioid modulatorTREVENA INC·Filed 2021·Application pending·0 cites
- 2545US2015361139A1Crystalline form of linaclotideSANDOZ AG·Filed 2014·Application pending·0 cites
- 2644US2018153879A1Solid Dispersion Comprising μ-Opioid AntagonistsSANDOZ AG·Filed 2017·Application pending·0 cites
- 2738US2017174720A9Cationic steroidal antimicrobial saltsSAVAGE PAUL B·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hayley Reece files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →